Franco Sicuro
Psychiatry · Olivette, MONPI 1629159207
Payments from drug & device makers
Across 833 payments — averaging $2760.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$771K
- Teva Pharmaceuticals USA, Inc.$419K
- Genentech, Inc.$340K
- Eisai Inc.$288K
- Boehringer Ingelheim$116K
- Avanir Pharmaceuticals, Inc.$96K
- plus $270K from 28 others
Across 10 payments — averaging $145.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$1K
What the payments were for
- Speaking & faculty fees$11,00066%
- Travel & lodging$1,3498%
- Food & beverage$4,22225%
- Education$1901%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,299,722 in reported general payments places this provider in the 95th percentile of 680 psychiatry providers in Missouri.
Other psychiatry in Olivette
- Gregory MattingleySaint Charles$8.2M
- Junaid SyedSaint Louis$8M
- Eric CarbonellFestus$5.4M
- Ricky MofsenSaint Louis$4.9M
- Charles ConwaySaint Louis$3.8M
- Mohd MalikSaint Louis$2.8M
- Howard IlivickySaint Charles$2.1M
- Vadim BaramSaint Louis$1.9M
- Gary LinkerFordland$1.6M
- Ganesh GopalakrishnaColumbia$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.